Item 1.01 Entry into a Material Definitive Agreement.
On
Under the terms of the Transfer Agreement, we have agreed to purchase all of the
outstanding equity of nine entities (the "
The names of the
PharmacyName Address
Jianyang Branch Huayuan ), No.17 Gongyuanhou Street ,Jiancheng Town , Jianyang City
Mianyang BranchFucheng District , Mianyang City
Co., Ltd.Wenjiang District , Chengdu City
Xinjin BranchWujin Town , Xinjin County
International, No. 9 Qingyun West Street,Jinjiang District ,Chengdu CityQionglai Weide Pharmacy No.40 Yudai Street ,Linqiong Town , Qionglai City
Ltd. District,Chengdu CityChengdu Beibang Pharmacy Co., Ltd. No. F55, No.6 Xingyuan 3rd Road , Wujin Town, Xinjin County,Chengdu City Chengdu Xindu District Cundetang No. F54, No.99 Pihe East Road , XinduPharmacy Co., Ltd. Street,Xindu District ,Chengdu City
The first of the nine pharmacies was established in 2016. Each of the pharmacies engages in the retail sale of pharmaceuticals; sales of pre-packaged food and bulk food, health food, dairy products, cosmetics, electronic products, disinfecting supplies, class-I, and class-II medical equipment and the staff at each pharmacy consults with customers regarding common nutrition and health issues, though they are not licensed to make a diagnosis and when appropriate refer customers to a physician.
We received an appraisal from
The Transfer Agreement contains customary representations, warranties, and covenants of the parties and post-closing indemnities. The representations and warranties set forth in the Agreement generally survive for 18 months following the closing.
The Company expects the closing of the acquisition to occur no later than
A copy of the Transfer Agreement is attached as an exhibit to this report on Form 8-K. The foregoing description of the Transfer Agreement does not purport to be complete and is qualified in its entirety by reference to the Transfer Agreement.
Item 9.01 Financial Statements and Exhibits.
(a) Financial statements of business acquired.
The financial statements required by Rule 8-04 of Regulation S-X will be filed by amendment to this Current Report on Form 8-K as soon as practicable, but in no event later than 71 calendar days after the date on which this Current Report on Form 8-K was required to be filed.
(b) Pro forma financial information
The pro forma financial information required pursuant to Rule 8-05 and Article 11 of Regulation S-X will be filed by amendment to this Current Report on Form 8-K as soon as practicable, but in no event later than 71 calendar days after the date on which this Current Report on Form 8-K was required to be filed.
Exhibit No. Description 10.1 Equity Transfer Agreement with respect toChengdu Aixin Pharmacy Co., Ltd. and affiliated entities
© Edgar Online, source